Lamoureux F

References (4)

Title : Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review - Raymond_2021_J.Pers.Med_11_
Author(s) : Raymond J , Imbert L , Cousin T , Duflot T , Varin R , Wils J , Lamoureux F
Ref : J Pers Med , 11 : , 2021
Abstract :
PubMedSearch : Raymond_2021_J.Pers.Med_11_
PubMedID: 33440670

Title : Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients - Duflot_2019_Cardiovasc.Diabetol_18_35
Author(s) : Duflot T , Moreau-Grange L , Roche C , Iacob M , Wils J , Remy-Jouet I , Cailleux AF , Leuillier M , Renet S , Li D , Morisseau C , Lamoureux F , Richard V , Prevost G , Joannides R , Bellien J
Ref : Cardiovasc Diabetol , 18 :35 , 2019
Abstract :
PubMedSearch : Duflot_2019_Cardiovasc.Diabetol_18_35
PubMedID: 30885203

Title : Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice - Marino_2019_EBioMedicine_44_452
Author(s) : Marino S , de Ridder D , Bishop RT , Renema N , Ponzetti M , Sophocleous A , Capulli M , Aljeffery A , Carrasco G , Gens MD , Khogeer A , Ralston SH , Gertsch J , Lamoureux F , Heymann D , Rucci N , Idris AI
Ref : EBioMedicine , 44 :452 , 2019
Abstract :
PubMedSearch : Marino_2019_EBioMedicine_44_452
PubMedID: 31151929

Title : Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases - Duflot_2014_Expert.Opin.Drug.Discov_9_229
Author(s) : Duflot T , Roche C , Lamoureux F , Guerrot D , Bellien J
Ref : Expert Opin Drug Discov , 9 :229 , 2014
Abstract :
PubMedSearch : Duflot_2014_Expert.Opin.Drug.Discov_9_229
PubMedID: 24490654